Preoperative chemotherapy for bladder cancer
Authors:
Open Access
Abstract
A retrospective study of neoadjuvant gemcitabine plus cisplatin in the current issue of Cancer highlights the activity of this regimen and its low frequency of employment. Directions for the further development of neoadjuvant therapy for bladder cancer are discussed.Keywords
This publication has 18 references indexed in Scilit:
- Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladderCancer, 2011
- Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomyBJU International, 2010
- The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary BladderClinical Cancer Research, 2010
- Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapyCancer, 2009
- Potential Impact of Postoperative Early Complications on the Timing of Adjuvant Chemotherapy in Patients Undergoing Radical Cystectomy: A High-Volume Tertiary Cancer Center ExperienceEuropean Urology, 2009
- Outcome of Patients With Bladder Cancer With pN+ Disease After Preoperative Chemotherapy and Radical CystectomyUrology, 2009
- Impact of renal impairment on eligibility for adjuvant cisplatin‐based chemotherapy in patients with urothelial carcinoma of the bladderCancer, 2006
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerNew England Journal of Medicine, 2003
- Integrated Therapy for Locally Advanced Bladder Cancer: Final Report of a Randomized Trial of Cystectomy Plus Adjuvant M-VAC Versus Cystectomy With Both Preoperative and Postoperative M-VACJournal of Clinical Oncology, 2001
- POST-CHEMOTHERAPY SURGERY IN PATIENTS WITH UNRESECTABLE OR REGIONALLY METASTATIC BLADDER CANCERJournal of Urology, 2001